Centaurus Financial, Inc. Global X Fds Genomics & Biotec Transaction History

Centaurus Financial, Inc.

$1.43 Billion
Q1 2025

A detailed history of Centaurus Financial, Inc. transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Centaurus Financial, Inc. holds 15,896 shares of GNOM stock, worth $138,454. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,896

Previous 15,796 0.63%

Holding current value

$138,454

Previous $153,000 17.65%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$7.95 - $10.29 $795 - $1,029	100 Added 0.63%	15,896 $126,000
Q4 2024 Mar 12, 2025	BUY	$9.62 - $11.13 $7,695 - $8,904	800 Added 5.33%	15,796 $153,000
Q3 2024 Nov 12, 2024	BUY	$10.32 - $11.8 $10,165 - $11,623	985 Added 7.03%	14,996 $168,000
Q2 2024 Sep 20, 2024	BUY	$9.68 - $11.36 $135,626 - $159,164	14,011 New	14,011 $146,000
Q4 2023 Feb 26, 2024	BUY	$8.77 - $11.77 $14,242 - $19,114	1,624 Added 14.61%	12,738 $147,000
Q3 2023 Nov 13, 2023	BUY	$10.07 - $12.5 $4,753 - $5,900	472 Added 4.44%	11,114 $113,000
Q2 2023 Aug 15, 2023	BUY	$11.99 - $13.07 $1,055 - $1,150	88 Added 0.83%	10,642 $128,000
Q1 2023 May 17, 2023	BUY	$11.73 - $14.18 $22,932 - $27,721	1,955 Added 22.74%	10,554 $130,000
Q4 2022 Feb 10, 2023	BUY	$12.08 - $13.81 $103,875 - $118,752	8,599 New	8,599 $108,000
Q2 2022 Aug 02, 2022	SELL	$10.66 - $15.9 $74,556 - $111,204	-6,994 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.33 - $19.98 $1,652 - $2,477	124 Added 1.8%	6,994 $105,000
Q4 2021 Feb 01, 2022	BUY	$19.42 - $22.42 $33,810 - $39,033	1,741 Added 33.94%	6,870 $136,000
Q3 2021 Nov 12, 2021	BUY	$21.89 - $25.16 $112,273 - $129,045	5,129 New	5,129 $114,000

Others Institutions Holding GNOM

# of Institutions

Shares Held

2.41M

Call Options Held

Put Options Held

4.8K

View Full List

About GLOBAL X FDS GENOMICS & BIOTEC

Ticker GNOM
Sector ETFs
Industry ETFs

More about GNOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Global X Fds Genomics & Biotec Transaction History